Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives-Reference-Cited by-同舟云学术

Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives

Published:1991-01 Issue:1 Volume:90 Page:584-589
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Haarbo Jens,Hassager Christian,Jensen Signe B.,Riis Bente J.,Christiansen Claus

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use;Wallace;Lancet,1979

2. Epidemiology of atherosclerosis: an updated overview;Criqui;Am J Cardiol,1986

3. A prospective study of postmenopausal estrogen therapy and coronary heart disease;Stamfer;N Engl J Med,1985

4. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program follow-up study;Bush;Circulation,1987

5. Estrogen replacement therapy in the menopause;Council Report;JAMA,1983

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipids and Lipoproteins and Effects of Hormone Therapy;Treatment of the Postmenopausal Woman;2007

2. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms;Archives of Gynecology and Obstetrics;2006-02-21

3. Update on cardiovascular disease in post-menopausal women;Best Practice & Research Clinical Obstetrics & Gynaecology;2002-06

4. Short-term oral estrogen replacement therapy does not augment endothelium-independent myocardial perfusion in postmenopausal women;American Heart Journal;2001-10

5. Low doses of estradiol in combination with gestodene to prevent early postmenopausal bone loss;American Journal of Obstetrics and Gynecology;2000-09